Healthcare provider profile · identity verified

Susan M. Sayers, MD

Family Practice · GRAND JUNCTION, CO · NPI 1891778494

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	299	79
Atorvastatin Calcium	Atorvastatin Calcium	255	68
Losartan Potassium	Losartan Potassium	174	40
Gabapentin	Gabapentin	136	31
Lisinopril	Lisinopril	131	39
Amlodipine Besylate	Amlodipine Besylate	120	37
Omeprazole	Omeprazole	117	32
Simvastatin	Simvastatin	109	29
Alprazolam	Alprazolam	97	23
Metformin Hcl	Metformin Hcl	95	24
Sertraline Hcl	Sertraline Hcl	90	24
Hydrochlorothiazide	Hydrochlorothiazide	70	25
Metoprolol Succinate	Metoprolol Succinate	70	19
Zolpidem Tartrate	Zolpidem Tartrate	68	17
Alendronate Sodium	Alendronate Sodium	67	17
Pantoprazole Sodium	Pantoprazole Sodium	66	15
Trazodone Hcl	Trazodone Hcl	66	20
Fluoxetine Hcl	Fluoxetine Hcl	65	15
Rosuvastatin Calcium	Rosuvastatin Calcium	64	16
Furosemide	Furosemide	53	14
Escitalopram Oxalate	Escitalopram Oxalate	48	14
Mounjaro	Tirzepatide	47	suppressed
Estradiol	Estradiol	46	15
Albuterol Sulfate Hfa	Albuterol Sulfate	39	17
Bupropion Xl	Bupropion Hcl	39	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	39	17
Spironolactone	Spironolactone	39	11
Clonazepam	Clonazepam	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Carvedilol	Carvedilol	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Atenolol	Atenolol	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Potassium Chloride	Potassium Chloride	31	11
Tamsulosin Hcl	Tamsulosin Hcl	31	suppressed
Acyclovir	Acyclovir	30	12
Cephalexin	Cephalexin	30	20
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Allopurinol	Allopurinol	29	suppressed
Ropinirole Hcl	Ropinirole Hcl	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Tramadol Hcl	Tramadol Hcl	27	suppressed
Lorazepam	Lorazepam	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Eliquis	Apixaban	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Buspirone Hcl	Buspirone Hcl	24	suppressed
Citalopram Hbr	Citalopram Hydrobromide	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	23	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Colesevelam Hcl	Colesevelam Hcl	21	suppressed
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Prednisone	Prednisone	21	14
Cilostazol	Cilostazol	20	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Progesterone	Progesterone, Micronized	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Fluticasone Propionate	Fluticasone Propionate	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Pravastatin Sodium	Pravastatin Sodium	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Ibandronate Sodium	Ibandronate Sodium	15	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Enbrel	Etanercept	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Famotidine	Famotidine	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error